Loading...
Market
Which company will announce a new vaccine for KP.3.1.1 by March 31, 2025?
2
Resolution / Starting Odds
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Company press releases and FDA announcements
Story
New COVID-19 Subvariant KP.3.1.1 Dominates 50% of U.S. Cases, CDC Data Shows
Sep 19, 2024, 10:30 AM
A new COVID-19 subvariant, KP.3.1.1, which began circulating in Europe over the summer, has now become the dominant strain in the United States. According to the CDC Nowcast data tracker, KP.3.1.1 has risen by 12.7% and now accounts for over 50% of COVID-19 cases in the country. Oklahoma experienced a peak in COVID-19 cases in August, but the emergence of this new variant is raising concerns nationwide. The CDC data highlights the rapid spread and dominance of this variant.
View original story
Similar markets
Pfizer • 25%
Moderna • 25%
AstraZeneca • 25%
Johnson & Johnson • 25%
Pfizer has the largest market share • 25%
Moderna has the largest market share • 25%
Novavax has the largest market share • 25%
Other companies have the largest market share • 25%
GlaxoSmithKline • 25%
Pfizer • 25%
Moderna • 25%
Other • 25%
GSK • 33%
Sanofi • 33%
Seqirus • 33%
Pfizer (KP.2) • 25%
Moderna (KP.2) • 25%
Novavax (JN.1) • 25%
All equally effective • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Sanofi • 25%
Other • 25%
Pfizer • 25%
Merck • 25%
Johnson & Johnson • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
Roche • 25%
Novartis • 25%
Influenza • 25%
Zika • 25%
HIV • 25%
Other • 25%
Company X • 25%
Company Y • 25%
Company Z • 25%
Other • 25%
